Pyrotinib in Women With High-risk in Early Stage Breast Cancer
Pyrotinib in Women With High-risk in Early Stage Breast Cancer
Recruiting · NCT05834764 · Registry updated 2023-04-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pyrotinib in Women With High-risk in Early Stage Breast Cancer | HER2-positive Breast Cancer | Recruiting | Phase 2 | 2023-04-28 | NCT05834764 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu HengRui Medicine Co., Ltd. | 132 |
| The First Affiliated Hospital with Nanjing Medical University | 319 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| JiangSu Province Hospital/ The First Affiliated Hospital of Nanjing Medical University | Nanjing | China | 1 |